Sensitive and real-time method for evaluating corneal barrier considering tear flow.
暂无分享,去创建一个
Takashi Kitahara | Hitoshi Sasaki | Shun Higuchi | H. Sasaki | S. Higuchi | Tadahiro Nakamura | T. Kitahara | M. Nakashima | K. Nishida | M. Uematsu | T. Kitaoka | J. Nakamura | Mugen Teshima | Mikiro Nakashima | Junzo Nakamura | Koyo Nishida | Tadahiro Nakamura | Mugen Teshima | Masafumi Uematsu | Takashi Kitaoka
[1] P. Artursson,et al. Mechanisms of absorption enhancement and tight junction regulation , 1994 .
[2] Hitoshi Sasaki,et al. Acute Corneal Epithelial Change after Instillation of Benzalkonium Chloride Evaluated Using a Newly Developed in vivo Corneal Transepithelial Electric Resistance Measurement Method , 2007, Ophthalmic Research.
[3] H. Sasaki,et al. Electrophysiological characterization of tight junctional pathway of rabbit cornea treated with ophthalmic ingredients. , 2007, Biological & pharmaceutical bulletin.
[4] J. Piontek,et al. Structure and function of claudins. , 2008, Biochimica et biophysica acta.
[5] S. Klyce. Relationship of epithelial membrane potentials to corneal potential. , 1973, Experimental eye research.
[6] Alessio Fasano,et al. Tight junction modulation and its relationship to drug delivery. , 2006, Advanced drug delivery reviews.
[7] J. Robinson,et al. Lacrimal and instilled fluid dynamics in rabbit eyes. , 1973, Journal of pharmaceutical sciences.
[8] S. Klyce,et al. Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium. , 1977, Investigative ophthalmology & visual science.
[9] C. Baudouin. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma , 2008, Acta ophthalmologica.
[10] P. Gastaud,et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. , 1998, Current eye research.
[11] Liying Wang,et al. The Transport Barrier of Epithelia: A Comparative Study on Membrane Permeability and Charge Selectivity in the Rabbit , 1992, Pharmaceutical Research.
[12] J. Nordmann,et al. Vision related quality of life and topical glaucoma treatment side effects , 2003, Health and quality of life outcomes.
[13] C. Baudouin,et al. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication , 2002, The British journal of ophthalmology.
[14] L. González-Mariscal,et al. Crosstalk of tight junction components with signaling pathways. , 2008, Biochimica et biophysica acta.
[15] P. Edman. Biopharmaceutics of Ocular Drug Delivery , 1992 .
[16] C. Baudouin,et al. New tools for the evaluation of toxic ocular surface changes in the rat. , 2007, Investigative ophthalmology & visual science.
[17] H. Sasaki,et al. Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.
[18] N. Burstein. Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. , 1980, Investigative ophthalmology & visual science.
[19] R. Noecker,et al. Corneal and Conjunctival Changes Caused by Commonly Used Glaucoma Medications , 2004, Cornea.
[20] R. Schoenwald,et al. Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors , 1983 .
[21] J. Robinson,et al. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. , 1974, Journal of pharmaceutical sciences.